Skip to main content
Article thumbnail
Location of Repository

British isles lupus assessment group 2004 index is valid for assessment of disease activity in systemic lupus erythematosus

By Chee-Seng Yee, Vernon Farewell, David A Isenberg, Anisur Rahman, Lee-Suan Teh, Bridget Griffiths, Ian N Bruce, Yasmeen Ahmad, Athiveeraramapandian Prabu, Mohammed Akil, Neil McHugh, David D'Cruz, Munther A Khamashta, Peter Maddison and Caroline Gordon
Topics: Life and Medical Sciences
Publisher: Wiley Subscription Services, Inc., A Wiley Company
OAI identifier: oai:pubmedcentral.nih.gov:2659367
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Citations

    1. A note on robust variance estimation for clustercorrelated data.
    2. (1992). and the SLE Study Group. The genetic basis of Ro and La antibody formation in systemic lupus erythematosus. Results of a multicenter study. Rheumatol Int
    3. (1992). Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus.
    4. Defining response in systemic lupus erythematosus: a study by the
    5. (2004). development and initial validation of an updated version of the British Isles Lupus Assessment Group’s disease activity index for patients with systemic lupus erythematosus. Rheumatology
    6. (1993). DR and complement C4 variants in systemic lupus erythematosus.
    7. Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3.
    8. (1987). Family study of the major histocompatibility complex in HLA DR3 negative patients with systemic lupus erythematosus. Clin Exp Immunol
    9. (1997). for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum
    10. (1992). Measurement of disease activity in systemic lupus erythematosus. Prospective validation of 3 clinical indices.
    11. (1988). Measurement of systemic lupus erythematosus activity in clinical research. Arthritis Rheum
    12. Renal flares are common in patients with severe proliferative lupus nephritis treated with pulse immunosuppressive therapy: long-term followup of a cohort of 145 patients participating in randomized controlled studies.
    13. (2004). Revised British Isles Lupus Assessment Group
    14. (1982). revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum
    15. (1988). Ro(SS-A) positive Sjo ¨gren’s/lupus erythematosus (SC/LE) overlap patients are associated with the HLA-DR3 and/or DRw6 phenotypes.
    16. (1994). Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation.
    17. (2000). Systemic Lupus Erythematosus Disease Activity Index
    18. (1993). The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus.
    19. (1999). The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol Rev

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.